Hong Kong Pharmaceuticals & Biotech Blue chip stocks

Innovent Biologics

Market Cap: HK$89.5b

A biopharmaceutical company, develops, manufactures and commercializes monoclonal antibodies and other drug assets in the fields of oncology, ophthalmology, autoimmune, and cardiovascular and metabolic diseases in China.

Akeso

Market Cap: HK$77.8b

A biopharmaceutical company, engages in the research, development, manufacturing, and commercialization of antibody drugs.

WuXi Biologics (Cayman)

Market Cap: HK$94.4b

An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.